306 related articles for article (PubMed ID: 15583115)
1. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
2. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
4. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
5. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
6. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
Licht RW; Qvitzau S
Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
[TBL] [Abstract][Full Text] [Related]
8. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
Niklson IA; Reimitz PE; Sennef C
Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
[TBL] [Abstract][Full Text] [Related]
9. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled trial of venlafaxine for the treatment of major depression.
Schweizer E; Weise C; Clary C; Fox I; Rickels K
J Clin Psychopharmacol; 1991 Aug; 11(4):233-6. PubMed ID: 1918421
[TBL] [Abstract][Full Text] [Related]
11. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA
Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
[TBL] [Abstract][Full Text] [Related]
12. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
Daléry J; Dagens-Lafant V; De Bodinat C
Encephale; 1997; 23(1):56-64. PubMed ID: 9172969
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic action lag time and resistance to treatment].
Peretti CS
Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
[TBL] [Abstract][Full Text] [Related]
14. Use of slow-release melatonin in treatment-resistant depression.
Dalton EJ; Rotondi D; Levitan RD; Kennedy SH; Brown GM
J Psychiatry Neurosci; 2000 Jan; 25(1):48-52. PubMed ID: 10721684
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
de Jonghe F; Swinkels J; Tuynman-Qua H
Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
[TBL] [Abstract][Full Text] [Related]
16. [Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes].
Lôo H; Poirier MF; Ollat H; Elatki S
Encephale; 2000; 26(2):70-5. PubMed ID: 10858919
[TBL] [Abstract][Full Text] [Related]
17. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
Bohacek N; Ravic M; Bizière K
Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
[TBL] [Abstract][Full Text] [Related]
18. Response to steroid suppression in major depression resistant to antidepressant therapy.
Murphy BE; Dhar V; Ghadirian AM; Chouinard G; Keller R
J Clin Psychopharmacol; 1991 Apr; 11(2):121-6. PubMed ID: 1829098
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
Feiger AD
Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
[TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
